1. The modulatory effect of taurine on benzo (a) pyrene-induced hepatorenal toxicity
- Author
-
Adegboyega K. Oyelere, Gideon Adeniyi, and Solomon E. Owumi
- Subjects
Paper ,medicine.medical_specialty ,Taurine ,Health, Toxicology and Mutagenesis ,Toxicology ,medicine.disease_cause ,Lipid peroxidation ,Superoxide dismutase ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,biology ,Chemistry ,Glutathione peroxidase ,Glutathione ,Endocrinology ,030220 oncology & carcinogenesis ,Toxicity ,biology.protein ,Liver function ,Oxidative stress - Abstract
Toxicities linked with Benzo (a) pyrene B[a]P exposure, particularly in liver and kidney have been reported in both animals and humans. Taurine (2-aminoethane sulfonic acid) is an intracellular β-amino acid reported to elicit hepatorenal protective functions. However, the modulatory effect of taurine on hepatorenal toxicity associated with exposure to B[a]P has not been reported. This study evaluated the effects of taurine on the hepatorenal toxicities induced in cohorts of rats exposed to B[a]P. Experimental rats were treated as follows: B[a]P (10 mg/kg); co-treated cohorts –B[a]P (10 mg/kg) plus taurine (100 or 200 mg/kg) for 4 successive weeks. Results show that co-dosing with taurine significantly (P
- Published
- 2020